A Study of LY4064809 in Healthy Adult Participants
NCT07339735
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Participants
Interventions
DRUG:
LY4064809 Test Formulation
DRUG:
LY4064809 Reference Formulation
Sponsor
Eli Lilly and Company